Share:
CANbridge Pharmaceuticals Inc., a company developing and commercializing innovative drugs to treat rare diseases and targeted cancers, announced that it has appointed Justin Lu to the position of General Manager of China, responsible for setting up and operating commercial operations in China. Mr. Lu will be based in Shanghai. Justin s proven expertise in pharmaceutical operations, developed over two decades at leading world-class companies, will allow CANbridge to build robust operations in China and carry us into the future as we grow our product portfolio, said James Xue, PhD, CANbridge Founder, Chairman and CEO. We are delighted to welcome him to the team.
E-Mail
WASHINGTON Machine learning, a form of artificial intelligence, can predict which women are at high risk of developing gestational diabetes and lead to earlier intervention, according to a new study published in the Endocrine Society s
Journal of Clinical Endocrinology & Metabolism.
Gestational diabetes is a common complication during pregnancy that affects up to 15 percent of pregnant women. High blood sugar in the mother can be dangerous for the baby and lead to complications like stillbirth and premature delivery. Most women are diagnosed with gestational diabetes during the second trimester, but some women are at high risk and could benefit from earlier intervention.
Artificial Intelligence Predicts Gestational Diabetes by Colleen Fleiss on December 22, 2020 at 11:10 PM
Machine learning helped predict women at high risk of developing gestational diabetes, revealed a new study published in the Endocrine Society s Journal of Clinical Endocrinology & Metabolism. Machine learning is a form of artificial intelligence.
Gestational diabetes is a common complication during pregnancy that affects up to 15 percent of pregnant women. High blood sugar in the mother can be dangerous for the baby and lead to complications like stillbirth and premature delivery. Most women are diagnosed with gestational diabetes during the second trimester, but some women are at high risk and could benefit from earlier intervention.
AI model identifies women at high risk for gestational diabetes, study finds
By (0)
Researchers in China have successfully used AI to identify women at high risk for gestational diabetes, a common pregnancy complication. Photo by Free-Photos/Pixabay
Dec. 22 (UPI) Artificial intelligence can effectively identify women at high risk for gestational diabetes during the first trimester, allowing treatment to begin at an earlier stage of the disease, according to a study published Tuesday by the Endocrine Society s Journal of Clinical Endocrinology & Metabolism.
Researchers in China used machine learning, a form of AI, to develop a model that can predict whether women will develop the disease about 80% of the time.